What is risk-based monitoring?

• A. Focus on critical data and processes.
• B. Monitor every data point equally.
• C. Ignore data quality.
• D. Only monitor consent forms.

Answer: (A)

Risk-based monitoring concentrates oversight on the data and processes that matter most for patient safety and data integrity. It begins with a formal risk assessment to identify critical data elements (such as primary safety and efficacy endpoints and verification of informed consent) and high‑risk study processes (like data capture quality, adverse event reporting, and protocol compliance). Instead of examining every data point equally, monitoring resources are allocated based on risk, using centralized data reviews, analytics, and predefined thresholds to flag issues, with targeted on-site or remote verification where needed. This enables earlier detection of problems, faster corrective actions, and a more efficient use of monitoring resources. It also aligns with regulatory guidance that supports proportionate, risk-based oversight rather than exhaustive, point-by-point data checks. In short, risk-based monitoring means prioritizing monitoring activities around the elements that most affect participant safety and the reliability of trial results.